Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7677919 | 0.95 | CYP2C19 (0.67) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL7681152 | 0.88 | CYP2D6 (0.55) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL7679598 | 0.83 | CYP3A4 (0.58) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL7679073 | 0.81 | CYP3A4 (0.45) | CYP2C19CYP3A4CYP2D6MAPK14PIK3CA | |
| SCHEMBL3181015 | 0.78 | CYP2C19 (0.74) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL3175514 | 0.76 | CYP2C19 (0.70) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL3173535 | 0.76 | CYP2C19 (0.70) | CYP2C19CYP3A4CYP2D6MEN1KMT2A | |
| SCHEMBL10154083 | 0.76 | PIK3CA (0.50) | CYP2C19CYP3A4PIK3CAALDH1A1 | |
| SCHEMBL10210050 | 0.76 | PIK3CA (0.50) | PIK3CA | |
| SCHEMBL24455060 | 0.75 | HRH4 (0.49) | CYP2C19CYP2D6MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455520-B1 | TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS | ASTRA ZENECA AB (SE) | 2002-09-24 | — | — | US | disclosed |